Key result
Between 2000 and 2016 in Yokohama City, human parechovirus was detected in 79 of 806 patients, with HPeV3 being the most prevalent genotype (66%) and predominantly affecting infants less than 2 months of age.
Observational (n=806)
Yes
Molecular surveillance in Yokohama City from 2000 to 2016 revealed that HPeV3 is the most prevalent human parechovirus genotype, primarily causing viral-induced fever in infants under 2 months of age.
Human parechovirus (HPeV) infections in Yokohama City, Japan, were surveyed from 2000 to 2016. The sequence of the VP1 region of HPeVs was used to construct a phylogenetic tree and to reveal the putative amino acid (aa) sequences. Phylogenetic analysis showed the presence of 3 genotypes in Yokohama City: HPeV1 (25 specimens), HPeV3 (86 specimens), and HPeV4 (2 specimens). HPeV1 was detected nearly every year, with the highest number detected in 2014. HPeV3 was not detected until 2005, but was detected over a 1- or 3-yr period thereafter. HPeV1 was most prevalent from July to November, whereas HPeV3 peaked in July and August each year. HPeV1 was mainly detected in patients with infectious gastroenteritis or respiratory tract infections. In contrast, 87% of HPeV3-positive cases were in patients less than 2 months of age with a viral-induced fever. An analysis of the aa sequence of VP1 revealed a divergence within the same HPeV genotype, which was useful in analyzing the emergence and re-emergence of HPeV infections during the survey period. These findings suggest that molecular analysis of HPeVs may contribute to a better understanding of its epidemiology.
No takes yet. Share an insight, caveat, or question.
Tomoko Momoki (2018) conducted an observational in Suspected human parechovirus or enterovirus infection (n=806). Human parechovirus (HPeV) infection was evaluated on Prevalence and genotype distribution of HPeV. Between 2000 and 2016 in Yokohama City, human parechovirus was detected in 79 of 806 patients, with HPeV3 being the most prevalent genotype (66%) and predominantly affecting infants less than 2 months of age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: